Literature DB >> 30046573

Loco-regional treatments on the liver transplant waiting list: unmasking hepatocellular carcinoma (HCC) biology.

Amine Benmassaoud1,2, Emmanuel A Tsochatzis1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30046573      PMCID： PMC6036069          DOI： 10.21037/hbsn.2018.02.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

Authors:  René Adam; Vincent Karam; Valérie Delvart; John O'Grady; Darius Mirza; Jurgen Klempnauer; Denis Castaing; Peter Neuhaus; Neville Jamieson; Mauro Salizzoni; Stephen Pollard; Jan Lerut; Andreas Paul; Juan Carlos Garcia-Valdecasas; Fernando San Juan Rodríguez; Andrew Burroughs
Journal:  J Hepatol       Date:  2012-05-16       Impact factor: 25.083

Review 2.  Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

Authors:  M Lesurtel; B Müllhaupt; B C Pestalozzi; T Pfammatter; P-A Clavien
Journal:  Am J Transplant       Date:  2006-08-25       Impact factor: 8.086

3.  Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Richard M Ruiz; Goran B Klintmalm; Srinath Senguttuvan; Sander S Florman; Brandy Haydel; Maarouf Hoteit; Matthew H Levine; David D Lee; C Burcin Taner; Elizabeth C Verna; Karim J Halazun; Rita Abdelmessih; Amit D Tevar; Abhinav Humar; Federico Aucejo; William C Chapman; Neeta Vachharajani; Mindie H Nguyen; Marc L Melcher; Trevor L Nydam; Constance Mobley; R Mark Ghobrial; Beth Amundsen; James F Markmann; Alan N Langnas; Carol A Carney; Jennifer Berumen; Alan W Hemming; Debra L Sudan; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Abbas Rana; Michael L Kueht; Christopher M Jones; Thomas M Fishbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

Review 4.  Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.

Authors:  Emmanuel A Tsochatzis; Giacomo Germani; Andrew K Burroughs
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

5.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

6.  Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma.

Authors:  Emmanuel Tsochatzis; Matteo Garcovich; Laura Marelli; Vassilis Papastergiou; Evangelia Fatourou; Manuel L Rodriguez-Peralvarez; Giacomo Germani; Neil Davies; Dominic Yu; Tu Vinh Luong; Amar P Dhillon; Douglas Thorburn; David Patch; James O'Beirne; Tim Meyer; Andrew K Burroughs
Journal:  Liver Int       Date:  2013-03-26       Impact factor: 5.828

7.  Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.

Authors:  Vatche G Agopian; Maud M Morshedi; Justin McWilliams; Michael P Harlander-Locke; Daniela Markovic; Ali Zarrinpar; Fady M Kaldas; Douglas G Farmer; Hasan Yersiz; Jonathan R Hiatt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

8.  A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.

Authors:  Francis Y Yao; Nathan M Bass; Bev Nikolai; Raphael Merriman; Timothy J Davern; Robert Kerlan; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2003-07       Impact factor: 5.799

9.  Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.

Authors:  Zhen Zeng; Jinyu Ren; Maura O'Neil; Jie Zhao; Brian Bridges; Josiah Cox; Bashar Abdulkarim; Timothy M Schmitt; Sean C Kumer; Steven A Weinman
Journal:  BMC Cancer       Date:  2012-12-07       Impact factor: 4.430

10.  Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.

Authors:  Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2016-02-26       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.